InforMS: You are a therapist who works with people who have problems with sex and intimacy. Where do you start? Jenny Glick: I talk with individuals and couples about their…
Read More
Since the mid-1800s we have known that multiple sclerosis is a progressive neurological disease with an unpredictable course. Back in the day, when someone was diagnosed with MS, it was…
NfL and GFAP as Measures of Disease Progression Prospective study to evaluate Neurofilament Light (NfL) and glial fibrillary acidic protein (GFAP) as biomarkers for disease progression over time in patients…
Biomarkers are biological markers that can be used in diagnosis, selecting treatments, and evaluating treatment responses. Having pre-collected samples is invaluable for this research, and the Biobank ensures that researchers…
A whole new family of drugs is currently being studied very aggressively for the treatment of MS: Tyrosine kinases Inhibitors. Tyrosine kinases (TYKs) are intracellular enzymes that play a key…
A biomarker is any measurable indicator that can reliably and accurately tell us about a biological state or medical condition. As we continue to learn more about MS and utilize…
With current disease modifying therapies (DMTs) we have several highly effective treatments that work for many people, but there is a percentage of the population for whom these medications do…
Repair of MS damage and the potential for the reversal of the effects of MS are always on the minds of doctors, researchers and those living with the disease. Despite…
Over the past several months, there has been increased interest in the relationship between the Epstein Barr Virus and multiple sclerosis. A study conducted by a Harvard University research team…
Not Exactly… But Vaccines and Boosters Remain Our Best Defense COVID-19 continues to twist and turn as new variants become more predominant. The BQ1 and BQ1.1 variants have become the…
You're Reading:
About the Author
Pete Broderick is the Marketing and Communications Manager at the Rocky Mountain MS Center. He is also the editor and one of the primary writers for InforMS Magazine.